Bit Capital Gmb H Hookipa Pharma Inc. Transaction History

Bit Capital Gmb H

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Feb 12, 2025	SELL	$0.61 - $0.83 $139,622 - $189,977	-228,889 Closed	0 $0
Q4 2023 Feb 12, 2025	BUY	$0.42 - $0.86 $17,395 - $35,618	41,417 Added 22.09%	228,889 $185 Million
Q3 2023 Feb 12, 2025	BUY	$0.58 - $0.91 $52,642 - $82,594	90,763 Added 93.85%	187,472 $115 Million
Q2 2023 Feb 12, 2025	BUY	$0.71 - $1.97 $23,933 - $66,406	33,709 Added 53.51%	96,709 $85.1 Million
Q1 2023 Feb 12, 2025	BUY	$0.72 - $1.03 $14,400 - $20,600	20,000 Added 46.51%	63,000 $46.4 Million
Q4 2022 Feb 12, 2025	BUY	$0.73 - $14.6 $31,390 - $627,800	43,000 New	43,000 $34.8 Million

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $89.9M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.